News
Latest news from CHV and our portfolio companies
Featured News
Acquisition expands Gore’s cardiac portfolio through a high-growth adjacency CAUTION: Investigational Device. Limited by federal (or United States) law to investigational use. Outside the United States, the device is intended…
Insights & Impacts: The latest from CHV
Study will assess the Company’s Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial
Funding Will Support Clinical Studies of the VelocityTM pAVF System in Patients with Chronic Kidney
PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company redefining cancer treatment with therapeutics
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health
Innovative Leader in AI-Powered Brain Health Solutions Strengthens Board with Accomplished Remote Patient Monitoring Executive
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads
Advancements help neurologists detect and analyze suspected seizure events from patients in home healthcare settings
Avive Solutions, Inc., the developer of the world’s most advanced connected automated external defibrillator (AED)
Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health